With the knowledge of our current findings, neutralizing IL-6 signalling in T cells could still be considered, though as a short-term therapy, during the early development of obesity or in a weight-loss programme as a combinational therapy to enhance the effectiveness of diet and exercise. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.